Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.
Messoud AshinaDimos D MitsikostasFaisal Mohammad AminPinar KokturkChristoph J SchankinGurdal SahinPatricia Pozo-RosichPaul J DormanTomáš NežádalAnne Christine PooleIsabel Pavão MartinsMarja-Liisa SumelahtiVerena Ramirez CamposAndrew H AhnLeonidas LyrasCristina TassorelliPublished in: Cephalalgia : an international journal of headache (2023)
PEARL interim results support the effectiveness and safety of fremanezumab for migraine prevention in a real-world population across several European countries.Trial registration: encepp.eu: EUPAS35111.